Conventional dogma applied to quinolones? Time for a change

J Antimicrob Chemother. 2001 Jun;47(6):893. doi: 10.1093/jac/47.6.893.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 4-Quinolones
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use*
  • Aza Compounds*
  • Clinical Trials as Topic
  • Fluoroquinolones*
  • Gatifloxacin
  • Humans
  • Moxifloxacin
  • Outcome Assessment, Health Care
  • Pneumococcal Infections / drug therapy*
  • Quinolines*
  • Respiratory Tract Diseases / drug therapy
  • Streptococcus pneumoniae / drug effects

Substances

  • 4-Quinolones
  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Gatifloxacin
  • Moxifloxacin